A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Clinical trial NCT04294667 · COMPLETED
Trial details
- NCT number
- NCT04294667
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-12
- Primary completion
- 2024-05-22
- Enrollment
- 321
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.